West Historical Valuation

WST Stock  USD 331.40  0.00  0.00%   
Some fundamental drivers such as market cap or West Pharmaceutical enterprice value can be analyzed from historical perspective to project value of the company into the future. Some investors analyze West Pharmaceutical valuation indicators such as Market Cap of 236.5 M or Working Capital of 0.0 to time the market or to short-sell their positions based on the trend in valuation ratios. It is a perfect tool to project the direction of West Pharmaceutical's future value.
  
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in West Pharmaceutical Services. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

About West Valuation Data Analysis

Valuation is the financial process of determining what West Pharmaceutical is worth. West Pharmaceutical valuation ratios put that insight into the context of a company's share price, where they serve as useful tools for evaluating and utilizing investment potential. West Pharmaceutical valuation ratios help investors to determine whether West Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in West with respect to the benefits of owning West Pharmaceutical security.

West Pharmaceutical Valuation Data Chart

Market Cap is likely to drop to about 236.5 M in 2024. Enterprise Value is likely to drop to about 252.4 M in 2024

Enterprise Value

Enterprise Value (or EV) is usually referred to as West Pharmaceutical theoretical takeover price. In the event of an acquisition, an acquirer would have to take on West Pharmaceutical debt, but would also pocket its cash. Enterprise Value is more accurate representation of West Pharmaceutical value than its market capitalization because it takes into account all of West Pharmaceutical Services existing debt. A measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization that includes the market capitalization, plus total debt, minority interest and preferred shares, minus total cash and cash equivalents.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for West Stock Analysis

When running West Pharmaceutical's price analysis, check to measure West Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy West Pharmaceutical is operating at the current time. Most of West Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of West Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move West Pharmaceutical's price. Additionally, you may evaluate how the addition of West Pharmaceutical to your portfolios can decrease your overall portfolio volatility.